The Connie Wofsy Women's HIV Study
康妮·沃夫西女性艾滋病毒研究
基本信息
- 批准号:7188647
- 负责人:
- 金额:$ 305.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-08-01 至 2007-12-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS and Cancer Specimen BankAIDS clinical trial groupAIDS preventionAIDS related cancerAbdomenAccession NumberAcetoneAcquired Immunodeficiency SyndromeAcuteAddressAdherenceAdministratorAdvisory CommitteesAffectAlcohol consumptionAliquotAnemiaAnnual ReportsAnti-Retroviral AgentsAnusAppendixApplications GrantsAppointmentAreaAttentionAuthorization documentationAwardBackBacteriaBacterial VaginosisBehavioralBiologyBiopsyBloodBlood CellsBlood specimenBoxingBreastBusinessesCD4 Lymphocyte CountCD8-Positive T-LymphocytesCaliforniaCandidiasisCaringCarpetCathetersCell CountCentral obesityCervicalCervical dysplasiaCessation of lifeChairpersonCharacteristicsChicagoChild CareChronicClinicClinicalClinical DataClinical ManagementCodeCohort StudiesCollaborationsCollectionColposcopyCommunicable DiseasesCommunitiesCommunity OutreachComputer AnalysisComputersConcept ReviewConditionConsentConsultConsultationsCorpus Luteum CystCoulter counterCounselingCountyCuretteDNADailyDataData CollectionData SetDatabase Management SystemsDatabasesDate of birthDentalDental cariesDepositionDermatologistDermatologyDevelopmentDevicesDiagnosisDiagnostic testsDirector&aposs Working GroupDiseaseDisruptionDistrict of ColumbiaDoseDropsDrug IndustryDrug KineticsDry IceDysplasiaEducational ActivitiesEducational process of instructingEndocrinologistEndocrinologyEnrollmentEnsureEpidemiologyEquipment and supply inventoriesEventExcisionFacultyFailureFatty LiverFatty acid glycerol estersFeedbackFellowshipFertilityFibrosisFinancial compensationFollow-Up StudiesFoodFoundationsFreezingFrequenciesFundingFutureGaysGenderGeneral HospitalsGenotypeGiftsGingivaGlandGoalsGonadal Steroid HormonesGrantGroup MeetingsGynecologyHIVHIV InfectionsHIV SeropositivityHairHandHealthHealth care facilityHemorrhageHepaticHepatitis BHepatitis CHepatitis C virusHepatotoxicityHighly Active Antiretroviral TherapyHolidaysHome environmentHospitalsHourHouseholdHousingHuman Herpesvirus 8Human PapillomavirusHuman ResourcesHuman immunodeficiency virus testHyperglycemiaImageImmunologicsImmunologyIncentivesIncidenceIndividualInfectionInformed ConsentInpatientsInstitutesInstitutionInstructionInsulin ResistanceInternationalInternational AIDSInterviewInterviewerIntravenousK-Series Research Career ProgramsLabelLaboratoriesLaboratory FindingLactic AcidosisLanguageLeadLeadershipLearningLeftLesionLettersLicensingLifeLinkLipoatrophyLipodystrophyLiquid substanceLiverLiver FibrosisLiver diseasesLocationLos AngelesLymphocyte SubsetMRI ScansMaiden NameMailsMalignant NeoplasmsManualsMeasurementMeasuresMedicalMedical RecordsMedical SurveillanceMedical centerMenstrual cycleMenstrual fluidMenstruationMetabolicMethodologyMethodsMicroscopeMitochondrial Carnitine Palmitoyltransferase PathwayModelingModificationMonitorMorbidity - disease rateNamesNational Cancer Advisory BoardNational Institute of Child Health and Human DevelopmentNational Institute of Diabetes and Digestive and Kidney DiseasesNatural HistoryNeedlestick InjuriesNew YorkNewsletterNitrogenNotificationNumbersNurse PractitionersObesityOccupational SafetyOnline SystemsOperative Surgical ProceduresOpportunistic InfectionsOralOral ManifestationsOral MedicineOral candidiasisOral mucous membrane structureOutcomeOutpatientsOvarian FolliclePainPanicPaperParticipantPathologistPathologyPatient Self-ReportPatientsPatternPelvic ExaminationPeriodontal DiseasesPeripheralPeripheral Blood Mononuclear CellPharmaceutical PreparationsPharmacologic SubstancePhasePilot ProjectsPlacementPlasmaPlayPoliciesPopulationPortraitsPre-Post TestsPremalignantPrevalencePrimary Health CarePrincipal InvestigatorPrintingPrivacyProblem SolvingProceduresProcessProfessional counselorProspective StudiesProtocols documentationProviderPublic HealthPublicationsPuncture biopsyPurposeQualifyingQuality ControlQuestionnairesRNARandomizedRandomized Controlled TrialsRateReadingRecommendationRecording of previous eventsRecruitment ActivityRegistriesRegulationReportingReproductive EndocrinologyResearchResearch DesignResearch InfrastructureResearch MethodologyResearch PersonnelResistanceResourcesRewardsRiskRisk FactorsRoentgen RaysRoleRunningSafetySalivaSalivarySalivary Gland DiseasesSalivary GlandsSamplingSan FranciscoScanningScheduleScientistSentinelSeriesSerumServicesSeveritiesShippingShipsShortness of BreathSiteSlideSmokeSocial ConditionsSocial Security NumberSocial WorkSourceSpainSpecific qualifier valueSpecimenSpecimen HandlingSpeedSterilization for infection controlStructureSummary ReportsSurvivorsSwabSystemTechniquesTelephoneTelephone NumberTemperatureTestingTimeTissue DonationsTissue SampleTissuesTo specifyToxic effectTrainingTransportationTravelTreatment ProtocolsTriageTubeTuberculosisUltrasonographyUnited StatesUnited States Department of Veterans AffairsUnited States National Institutes of HealthUniversitiesUpdateUrineVaginaVaginal DouchingVenousVial deviceViralViral Load resultVirusVisceralVisitWeekWithdrawalWomanWomen&aposs HealthWorkWorkplaceWritingX-Ray Computed Tomographyanalogbaseblindchemokine receptorclinical research siteclinically relevantcohortcold temperaturecommunity organizationscommunity planningcomparativecomparison groupcomputer generatedcomputerizedconceptcostdata managementdaydesigndrug testingexperiencefallsfollow-uphealth care referralhealth care service utilizationhousing instabilityhydroxyureaimprovedindexinginnovationinsightinstrumentinterestliver biopsyliver imagingmalignant breast neoplasmmembermenmillilitermutantnon-nucleoside reverse transcriptase inhibitorsnucleoside analogoral lesionorganizational structureparolephysical abusepost-doctoral trainingpreferencepreventprobationprogramsproliferative phase Menstrual cycleprospectivepsychosocialreceptor densityrepositoryreproductiveresearch facilityresearch studysample collectionsatisfactionsexsocialstatisticssuccesssymposiumtertiary caretooltraittrendvirology
项目摘要
DESCRIPTION ( provided by applicant) This application for the Northern California WIHS site (the Connie Wofsy Women's HIV Study -- CWWHS) is divided into three sections, as per RFA instructions. The first section reports the contributions of our site to the WIHS progress, including cohort and sub study recruitment and retention, scientific leadership, and contributions to organizational leadership. This section contain several standardized tables (the numbers were provided by WDMAC) as well as a table summarizing the activities at our site.
The second section provides methods for the research proposed for WIHS III (scientific rationale discussed in Part A). This section provides methods for retention of participants, incorporations of WIHS III protocol modifications, site structure and scientific leadership.
The third section describes a proposal for a pilot study of hepatic steatosis among the CWWHS participants. This study, proposed by site investigators Phyllis Tien and Carl Grunfeld and two UCSF-based hepatologists, Norah Terrault and Teresa Wright, defines the incidence and prevalence of hepatic steatosis (HS) among HCV-infected women and factors associated with HS, such as obesity, body habitus changes (defined using DXA imaging) and nucleoside analog therapy. This study will also evaluate the accuracy of computerized tomography in detecting HS compared with percutaneous needle biopsy. This pilot project will also provide insight into the feasibility of this kind of intensive sub study in WIHS.
The WIHS III will also provide us with the opportunity to work with new UCSF investigators. In addition to those listed above, this proposal introduces Lewis Sheiner and Joseph Guglielmo (clinical pharmacologists) into the treatment exposure and resistance team and Robert Taylor (reproductive endocrinologist) to the new WIHS initiative on sex steroids. Overall, we are delighted to have this opportunity to propose continued work with the WIHS cohort, which we believe can provide unique and important findings on a representative group of HIV -infected and at-risk women in the United States.
根据RFA说明,描述(由申请人提供)此申请申请(Connie Wofsy妇女艾滋病毒研究-CWWHS)分为三个部分,如RFA指示。第一部分报告了我们网站对WIHS进步的贡献,包括队列和Sub研究招聘和保留,科学领导以及对组织领导的贡献。本节包含几个标准表(由WDMAC提供的数字)以及汇总我们网站活动的表。
第二部分为WIHS III提出的研究提供了方法(A部分中讨论的科学原理)。本节提供了保留参与者,WIHS III协议修改,现场结构和科学领导力的方法。
第三部分描述了CWWHS参与者中肝脂肪变性的试点研究的提案。现场研究人员Phyllis Tien和Carl Grunfeld以及两名基于UCSF的肝病学家Norah Terrault和Teresa Wright提出的这项研究定义了肝脂肪变性(HS)的发病率和流行率(HS)在HCV感染的妇女中,与肥胖症,习惯相关的HS中的因素(例如,使用了习惯,使用型)使用了DXA和DXA的nuciDing there(例如肥胖症)。这项研究还将评估计算机断层扫描在检测HS中的准确性,与经皮针活检相比。该试点项目还将深入了解WIHS中这种强化子研究的可行性。
WIHS III还将为我们提供与新的UCSF调查人员合作的机会。除了上面列出的那些建议外,该提案还将刘易斯·希纳(Lewis Sheiner)和约瑟夫·古利埃尔莫(Joseph Guglielmo)(临床药理学家)引入治疗暴露和抵抗小组,以及罗伯特·泰勒(Robert Taylor)(生殖内分泌学家),以实现性类固醇的新WIHS倡议。总体而言,我们很高兴有机会与WIHS队列进行持续的工作,我们认为这可以为美国的艾滋病毒感染和高危妇女提供独特而重要的发现。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RUTH Martha GREENBLATT其他文献
RUTH Martha GREENBLATT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RUTH Martha GREENBLATT', 18)}}的其他基金
Innovative methods for measuring antiretroviral exposure
测量抗逆转录病毒暴露的创新方法
- 批准号:
8102620 - 财政年份:2010
- 资助金额:
$ 305.6万 - 项目类别:
WIHS ANTIRETROVIRAL TREATMENT EXPOSURE STUDY
WIHS 抗逆转录病毒治疗暴露研究
- 批准号:
7202646 - 财政年份:2005
- 资助金额:
$ 305.6万 - 项目类别:
CONNIE WOFSY WOMEN'S INTERAGENCY HIV STUDY (WIHS) - NORTHERN CA
CONNIE WOFSY 妇女机构间艾滋病毒研究 (WIHS) - 加利福尼亚州北部
- 批准号:
7202597 - 财政年份:2005
- 资助金额:
$ 305.6万 - 项目类别:
WOMEN?S INTERAGENCY HIV STUDY SEX STEROIDS PROTOCOL
妇女机构间艾滋病毒研究性类固醇协议
- 批准号:
7202666 - 财政年份:2005
- 资助金额:
$ 305.6万 - 项目类别:
Innovative methods for measuring antiretroviral exposure
测量抗逆转录病毒暴露的创新方法
- 批准号:
7448642 - 财政年份:2005
- 资助金额:
$ 305.6万 - 项目类别:
Innovative methods for measuring antiretroviral exposure
测量抗逆转录病毒暴露的创新方法
- 批准号:
7615657 - 财政年份:2005
- 资助金额:
$ 305.6万 - 项目类别:
相似海外基金
Hormone Therapy for Peri- and Postmenopausal Women with HIV (HoT)
感染艾滋病毒的围绝经期和绝经后妇女的激素治疗 (HoT)
- 批准号:
10698682 - 财政年份:2023
- 资助金额:
$ 305.6万 - 项目类别:
KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH
KEMRI-PHRD UG1 级联网络单元:艾滋病毒感染女性的宫颈癌预防研究
- 批准号:
10763054 - 财政年份:2023
- 资助金额:
$ 305.6万 - 项目类别:
Screen Smart: Using Digital Health to Improve HIV Screening and Prevention for Adolescents in the Emergency Department
智能屏幕:利用数字健康改善急诊科青少年的艾滋病毒筛查和预防
- 批准号:
10711679 - 财政年份:2023
- 资助金额:
$ 305.6万 - 项目类别:
SUPPORT SERVICES FOR HIV AIDS CLINICAL TRIAL NETWORKS
HIV 艾滋病临床试验网络的支持服务
- 批准号:
10872942 - 财政年份:2023
- 资助金额:
$ 305.6万 - 项目类别: